首页> The Journal of Allergy and Clinical Immunology> Cost-effectiveness analysis of fluticasone versus montelukast in children with mild-to-moderate persistent asthma in the Pediatric Asthma Controller Trial.

Cost-effectiveness analysis of fluticasone versus montelukast in children with mild-to-moderate persistent asthma in the Pediatric Asthma Controller Trial.

导出原文传递

翻译打印收藏纠错

第一作者： Wang L

作者： Wang L ^[1] ; Hollenbeak CS ; Mauger DT ; Zeiger RS ; Paul IM ; Sorkness CA ; Lemanske RF Jr ; Martinez FD ; Strunk RC ; Szefler SJ ; Taussig LM

作者单位： Department of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA. ^[1]

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

The Journal of Allergy and Clinical Immunology

2011年127卷1期

161-166页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

The Journal of Allergy and Clinical Immunology

2011年127卷1期

161-166页

检索历史清除

Cost-effectiveness analysis of fluticasone versus montelukast in children with mild-to-moderate persistent asthma in the Pediatric Asthma Controller Trial.

The Journal of Allergy and Clinical Immunology

相似文献

同项目论文

The Journal of Allergy and Clinical Immunology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Cost-effectiveness analysis of fluticasone versus montelukast in children with mild-to-moderate persistent asthma in the Pediatric Asthma Controller Trial.

The Journal of Allergy and Clinical Immunology

相似文献

同项目论文

The Journal of Allergy and Clinical Immunology

相关期刊

检索历史清除